Consult
Log In
Menu
Consult
Log in

by PierianDx, on June 16, 2021

Comprehensive Genetic Profiling Supplements Germline and Companion Diagnostic Results to Provide Holistic View for Oncologists and Patients

Read Story
Topics:News

by PierianDx, on December 1, 2020

Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reporting 

Read Story
Topics:News

by PierianDx, on November 18, 2020

Mark McDonough named as Chief Executive Officer (CEO) and member of the Board of Directors of PierianDx 

Read Story
Topics:News

by PierianDx, on October 14, 2020

Multiple targeted assays from Pillar Biosciences to be combined with the PierianDx platform to reduce time, cost, and complexity of clinical genomic testing

Read Story
Topics:News

by PierianDx, on May 5, 2020

Collaboration will create integrated clinical interpretation and reporting solution

Read Story
Topics:News

by PierianDx, on December 11, 2019

Intermountain Healthcare joins PierianDx’s partner network to accelerate precision medicine

Read Story
Topics:News

by PierianDx, on October 28, 2019

Funding led by ATW Partners and SJF Ventures with follow-on Investment from Health Catalyst Capital, RTI International, and Inova Health Systems

Read Story
Topics:News

by PierianDx, on January 4, 2019

Comprehensive pan-cancer tumor profiling assays to be combined with clinical informatics platform with the potential to reduce time, cost, and complexity of clinical genomic analysis

Read Story
Topics:News

by Josh Forsythe, on June 11, 2018

PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that the Department of Anatomical Pathology PathWest Laboratory Medicine will use the company’s Clinical Genomics WorkSpace™ (CGW) platform, the industry’s leading integrated workspace for clinical genomic analytics, classification, interpretation and reporting.

Read Story
Topics:News

by Josh Forsythe, on June 1, 2018

Topics:News

by Josh Forsythe, on May 23, 2018

MAY 24, 2018 -- ST. LOUIS -- PierianDx, the leader in clinical genomics solutions, announced today that it has appointed Michael L. Sanderson as Chief Executive Officer and Director of the Board. In his new role, Sanderson will execute on the company’s strategy to integrate PierianDx’s unique value proposition for molecular labs into the broader precision medicine and healthcare delivery markets.

Read Story
Topics:News

by Josh Forsythe, on May 13, 2018

MAY 14, 2018 -- ST. LOUIS -- PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that it has executed a distribution agreement with ScienceVision, a leading provider of end-to-end genomic solutions in the Asia Pacific region.

Read Story
Topics:News